![]()
|
|
||||||||
(Received for publication, July 23, 1996, and in revised form, September 12, 1996)
From the ¶ Protein Engineering Network of Centres of
Excellence, University of Alberta, Edmonton, Alberta T6G 2S2,
Canada, The study of human transforming growth factor-
Volume 271, Number 50,
Issue of December 13, 1996
pp. 32204-32211
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
(TGF-
)-Epidermal Growth Factor Receptor Complex
VISUALIZATION OF HUMAN TGF-
BINDING DETERMINANTS THROUGH
NUCLEAR OVERHAUSER ENHANCEMENT ANALYSIS
,
,
Berlex Biosciences, Richmond, California 94804, and the " Biotechnology Research Institute, Montreal,
Quebec H4P 2R2, Canada
(TGF-
) in complex with the epidermal growth factor (EGF) receptor
extracellular domain has been undertaken in order to generate
information on the interactions of these molecules. Analysis of
1H NMR transferred nuclear Overhauser enhancement data for
titration of the ligand with the receptor has yielded specific data on
the residues of the growth factor involved in contact with the larger protein. Significant increases and decreases in nuclear Overhauser enhancement cross-peak intensity occur upon complexation, and interpretation of these changes indicates that residues of the A- and
C-loops of TGF-
form the major binding interface, while the B-loop
provides a structural scaffold for this site. These results corroborate
the conclusions from NMR relaxation studies (Hoyt, D. W., Harkins, R. N., Debanne, M. T., O'Connor-McCourt, M., and Sykes, B. D. (1994)
Biochemistry 33, 15283-15292), which suggest that the
C-terminal residues of the polypeptide are immobilized upon receptor
binding, while the N terminus of the molecule retains considerable
flexibility, and are consistent with structure-function studies of the
TGF-
/EGF system indicating a multidomain binding model. These
results give a visualization, for the first time, of native TGF-
in
complex with the EGF receptor and generate a picture of the
ligand-binding site based upon the intact molecule. This will
undoubtedly be of utility in the structure-based design of TGF-
/EGF
agonists and/or antagonists.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
C. McInnes, S. Grothe, M. O'Connor-McCourt, and B. D. Sykes NMR study of the differential contributions of residues of transforming growth factor alpha to association with its receptor Protein Eng. Des. Sel., March 1, 2000; 13(3): 143 - 147. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. McInnes, J. Wang, A.-E. A. Moustafa, C. Yansouni, M. O'Connor-McCourt, and B. D. Sykes Structure-based Minimization of Transforming Growth Factor-alpha (TGF-alpha ) through NMR Analysis of the Receptor-bound Ligand. DESIGN, SOLUTION STRUCTURE, AND ACTIVITY OF TGF-alpha 8-50 J. Biol. Chem., October 16, 1998; 273(42): 27357 - 27363. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. M. van de Poll, M. J. H. van Vugt, A. E. G. Lenferink, and E. J. J. van Zoelen Identification of the Minimal Requirements for Binding to the Human Epidermal Growth Factor (EGF) Receptor Using Chimeras of Human EGF and an EGF Repeat of Drosophila Notch J. Biol. Chem., June 26, 1998; 273(26): 16075 - 16081. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Aizawa, Y. Hayakawa, A. Ohnishi, N. Fujitani, K. D. Clark, M. R. Strand, K. Miura, N. Koganesawa, Y. Kumaki, M. Demura, et al. Structure and Activity of the Insect Cytokine Growth-blocking Peptide. ESSENTIAL REGIONS FOR MITOGENIC AND HEMOCYTE-STIMULATING ACTIVITIES ARE SEPARATE J. Biol. Chem., August 17, 2001; 276(34): 31813 - 31818. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |